CAP-XX Limited (AIM:CPX)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 12.46M |
| Revenue (ttm) | 2.56M |
| Net Income (ttm) | -1.87M |
| Shares Out | 5.80B |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 60,605,184 |
| Average Volume | 20,890,496 |
| Open | 0.221 |
| Previous Close | 0.230 |
| Day's Range | 0.200 - 0.240 |
| 52-Week Range | 0.110 - 0.490 |
| Beta | 1.38 |
| RSI | 43.40 |
| Earnings Date | Feb 2, 2026 |
About CAP-XX
CAP-XX Limited, together with its subsidiaries, develops, manufactures, and sells supercapacitors in the Asia Pacific, Europe, and the Americas. The company offers prismatic ultra-thin, lithium ion hybrid, cylindrical, and coin cell supercapacitors. Its products are used in the aerospace, transportation, green energy, electronics, industrial, and defense applications. The company was incorporated in 1990 and is based in Seven Hills, Australia. [Read more]
Financial Performance
In fiscal year 2025, CAP-XX's revenue was 4.94 million, an increase of 7.54% compared to the previous year's 4.59 million. Losses were -3.93 million, -36.10% less than in 2024.
Financial numbers in AUD Financial StatementsNews
CAP-XX Earnings Call Transcript: H1 2026
Revenue grew 9% year-over-year with bookings up 31% and backlog up 132%, while net loss and EBITDA loss both improved. Cash on hand reached AUD 2.9 million, with no debt and all legal cases closed. Expansion into new markets and product lines supports a positive outlook.
CAP-XX Transcript: AGM
The AGM covered board elections, adoption of a new constitution, auditor appointment, and authorization for future securities issuance. All five resolutions passed with 89–91% support from shareholders, representing 28.58% of issued share capital.
AIM Market Roundup: Rentguarantor, Medpal AI, Cap-xx
RentGuarantor, Medpal AI, Cap-XX are today's top risers, while Buccaneer Energy, Eqtec take the biggest fall on London's AIM market
CAP-XX Earnings Call Transcript: H2 2025
Revenue grew 8% in FY2025 with strong margins and reduced losses, driven by operational improvements and expanded distribution. Bookings and billings are up in early FY2026, and management expects continued growth and progress toward profitability.
AIM Market Roundup: Westmount Energy, Simec Atlantis, CAP-XX
Westmount Energy, Simec Atlantis, CAP-XX are today's top risers, while GENinCode, Polarean Imaging take the biggest fall on London's AIM
AIM Market Roundup: River Global, Argentex, CAP-XX
River Global, Argentex, CAP-XX are today's top risers, while Mpac, Kitwave take the biggest fall on London's AIM market
AIM Market Roundup: Zenova, CAP-XX, Eden Research
Zenova, CAP-XX, Eden Research are today's top risers, while Revolution Beauty, Arkle Resources take the biggest fall on London's AIM market
CAP-XX Earnings Call Transcript: H1 2025
Revenue grew 6.8% year-on-year, with strong APAC performance and reduced losses from cost-cutting. New partnerships and product launches are driving growth, and cash reserves are expected to last up to 24 months as the company targets break-even without further capital raises.
CAP-XX Transcript: AGM 2025
The meeting covered board changes, strong director re-elections, and approval of a share capital policy. Shareholders' questions addressed strategic growth, product development, and market expansion, with objectives set for market share growth and positive cash flow in 2025/26.
Three Quick Facts: Boohoo, DS Smith and CAP-XX
New CEO appointed as boohoo battles Frasers, DS Smith acquirer IPS issues results and CAP-XX funding round oversubscribed
Small Cap Stocks: Microsalt, Proton Motor Power, Eckoh
Microsalt, Proton Motor Power, Eckoh, CAP-XX and Shield Therapeutics are today's biggest Small Cap risers and fallers at the market close